Price $22.53 |
Market Cap
316.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.1
|
P/S
2.1
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
109.3
|
Op. Cash Flow
9K
|
FCF
0.2
|
|
Op. Margin
-1.50%
|
Net Margin
-1.10%
|
ROE
-0.60%
|
ROI
1.50%
|
|
ROA
-0.50%
|
EPS Growth
94.10%
|
Current Ratio
5.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Soligenix Inc (SNGX) | $0.55 | - | - | 24.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.82 | - | - | 150.9M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.65 | - | - | 78.2M | Strong Buy |
| Cyclo Therapeutics Inc (CYTH) | $2.10 | - | - | 19.4M | Strong Buy |
| Eton Pharmaceuticals Inc (ETON) | $2.96 | - | - | 76.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
